IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — AGEN

Balance Sheet

(in billions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.030.000.010.020.040.090.050.110.140.160.210.230.250.260.070.12
Short-term Investments----------------0.010.020.010.010.010.00----
Accounts Receivable0.010.000.000.000.000.000.000.000.000.000.010.020.000.020.000.00
Total Current Assets0.100.130.010.020.050.100.060.130.170.210.250.290.290.310.090.14
Property, Plant & Equipment0.010.020.110.120.120.130.130.140.140.140.100.090.080.050.030.03
Goodwill0.020.020.020.020.020.020.020.020.020.030.020.020.020.020.020.02
Intangible Assets0.000.000.000.000.000.000.000.000.000.010.010.010.010.010.010.01
Total Non-current Assets*0.090.100.170.180.190.190.200.210.210.210.180.170.150.130.100.10
Total Assets0.190.230.190.200.240.290.260.340.380.410.430.460.440.440.190.23
Accounts Payable0.070.090.070.060.050.050.050.040.050.050.040.040.030.030.020.02
Total Current Liabilities0.250.290.230.210.270.270.260.200.200.190.170.160.160.150.170.14
Long-term Debt0.030.030.030.030.000.000.000.010.010.01----0.010.010.020.02
Total Non-current Liabilities*0.160.220.310.330.260.260.200.270.270.280.280.290.260.250.270.29
Total Liabilities*0.410.510.540.540.530.530.460.460.480.470.450.450.430.400.440.42
Retained Earnings(2.14)(2.17)(2.24)(2.21)(2.14)(2.07)(2.02)(1.91)(1.85)(1.78)(1.64)(1.58)(1.54)(1.42)(1.60)(1.52)
Total Stockholder Equity(0.22)(0.27)(0.35)(0.34)(0.29)(0.24)(0.20)(0.13)(0.09)(0.06)(0.02)0.000.020.04(0.25)(0.19)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue33.7434.2030.2425.6924.0726.8425.1123.5128.0183.8024.3125.3022.9028.3922.7720.9325.9420.26252.9510.73
Cost of Revenue0.000.000.640.240.140.120.150.120.110.260.300.252.297.690.312.020.540.880.820.67
Gross Profit33.7434.2029.5925.4523.9326.7224.9751.2927.9083.5424.0125.0420.6120.6922.4618.9025.4019.38252.1410.06
Research & Development11.827.5123.6026.7121.5233.7741.0636.7743.9366.7251.4459.2957.1253.2846.0144.9642.4453.4942.9445.51
Selling, General & Admin6.8612.3010.8615.5215.7220.9317.2716.8216.8621.1818.9120.4218.2425.0418.1118.9118.9521.9721.3916.65
Total Operating Expenses18.6819.8134.1442.1637.2452.6256.47114.3760.7887.7470.3579.7174.9578.4564.1163.4760.8673.4164.6076.46
Operating Income15.0514.40(4.54)(16.71)(13.31)(25.90)(31.50)(30.19)(32.88)(4.20)(46.34)(54.67)(54.34)(57.76)(41.64)(44.56)(35.46)(54.03)187.54(66.39)
Net Income39.21(10.61)63.91(30.01)(26.37)(46.81)(67.21)(54.80)(63.45)(48.58)(64.53)(73.43)(70.89)(74.10)(56.71)(49.23)(50.60)(67.61)177.28(83.99)
Basic EPS1.030.032.00(1.00)(1.03)(1.95)(3.08)(2.52)(3.04)(0.11)(0.16)(0.20)(0.22)(0.24)(0.19)(0.17)----0.76--
Diluted EPS1.020.091.94(1.00)(1.03)(1.95)(3.08)(2.52)(3.04)(0.11)(0.16)(0.20)(0.22)(0.24)(0.19)(0.17)----0.72--

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(35.95)(16.62)(14.74)(20.22)(25.62)(28.65)(53.29)(38.18)(38.19)(40.40)(65.23)(60.04)(58.53)(47.34)(32.19)(43.45)(52.39)(22.93)131.37(55.56)
Capital Expenditures0.000.000.000.000.010.070.010.460.040.223.454.441.8414.3515.7218.454.548.9622.392.27
Free Cash Flow*(35.95)(16.62)(14.74)(20.22)(25.62)(28.72)(53.30)(38.64)(38.23)(40.62)(68.68)(64.48)(60.37)(61.68)(47.91)(61.90)(56.93)(31.89)108.99(57.83)
Investing Cash Flow68.950.780.080.280.06(0.02)0.06(0.24)0.232.8211.550.52(11.49)(6.38)(15.64)(4.06)(7.53)(13.30)(27.38)(2.27)
Financing Cash Flow(0.99)15.376.6810.943.5924.374.5679.0814.837.3218.0438.2656.2523.7728.2227.8016.0471.6178.9111.79

* Derived from reported values